Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Head Oncology Programs at Roche Innovation Center Zurich
Dr. Christian Klein is Distinguished Scientist and Department Head Cancer Immunotherapy Discovery at the Roche Innovation Center Zurich, specialized in the discovery, validation and preclinical development of antibody-based cancer immunotherapies and bispecific antibodies. During his 16 years at Roche he has made major contributions to the development and approval of obinutuzumab, the preclinical development of currently nine clinical stage bispecific antibodies/antibody fusion proteins, and the development of Roche’s proprietary bispecific antibody platforms e.g. the CrossMAb technology and immunocytokine and T-cell bispecific antibody platforms. 2017 he completed his habilitation in biochemistry at the Ludwig-Maximilians University Munich and acts as external lecturer there.